Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Cancer|November 2, 2022
Effectiveness of triennial screening with clinical breast examination: 14-years follow-up outcomes of randomized clinical trial in Trivandrum, IndiaKunnambath Ramadas, Partha Basu, Beela S Mathew, et al.Nature Medicine|June 25, 2024
A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trialPartha Basu, Mulindi Mwanahamuntu, Leeya F Pinder, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 14, 2026
Quality of life trajectories in breast cancer survivors up to one year after treatment: a prospective study in a lower-middle-income countryFarida Selmouni, Karima Bendahhou, Richard Muwonge, et al.BMC Cancer|May 3, 2022
Evolution of patterns of care for women with cervical cancer in Morocco over a decadeAbdellatif Benider, Karima Bendahhou, Catherine Sauvaget, et al.Cancer|June 5, 2024
Impact of clinical breast examination-based screening program on care pathway, stage at diagnosis, nature of treatment, and overall survival among breast cancer patients in MoroccoFarida Selmouni, Karima Bendahhou, Catherine Sauvaget, et al.European Journal of Public Health|July 9, 2025
Creating a data processing warehouse to support performance monitoring of cancer screening programmes in Europe using a common set of indicatorsEric Lucas, Nadya Dimitrova, Mariano Tomatis, et al.The Lancet. Oncology|September 29, 2022
Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling studyIrene Man, Damien Georges, Tiago M de Carvalho, et al.Oral Oncology|November 19, 2022
Impact of HPV vaccination on HPV-related oral infectionsTarik Gheit, Richard Muwonge, Eric Lucas, et al.BMJ Global Health|November 6, 2023
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in IndiaTiago M de Carvalho, Irene Man, Damien Georges, et al.Plos One|October 17, 2017
Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD studyMarisa Mena, Belen Lloveras, Sara Tous, et al.Pageof 12